
This Movember, we're highlighting research that is changing how testicular cancer is detected and monitored. Aditya Bagrodia, MD, a Moores Cancer Center member and urologic oncologist at UC San Diego Health, helped develop the first mRNA blood test for testicular cancer to become available in the United States. Developed through a decade of research, the test offers a less-invasive approach to detecting and monitoring testicular cancer, helping physicians make more informed, personalized treatment decisions while potentially reducing the need for repeated CT imaging. As we recognize Movember and its focus on men's health, this advancement underscores the importance of continued research, early detection and improving care for people affected by testicular cancer. Learn more: Read about this advancement: bit.ly/4t1aaT0 Watch Dr. Bagrodia discuss his work: bit.ly/4iWHhTo #Movember #TesticularCancer #MensHealth #CancerResearch #MooresCancerCenter

















